Immunological and Antitumor Effects of IL-23 as a Cancer Vaccine Adjuvant

The promising, but modest, clinical results of many human cancer vaccines indicate a need for vaccine adjuvants that can increase both the quantity and the quality of vaccine-induced, tumor-specific T cells. In this study we tested the immunological and antitumor effects of the proinflammatory cytok...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Overwijk, Willem W., de Visser, Karin E., Tirion, Felicia H., de Jong, Laurina A., Pols, Thijs W. H., Velden, Yme U. van der, Boorn, Jasper G. van den, Keller, Anna M., Buurman, Wim A., Theoret, Marc R., Blom, Bianca, Restifo, Nicholas P., Kruisbeek, Ada M., Kastelein, Robert A., Haanen, John B. A. G.
Formato: Artigo
Idioma:Inglês
Publicado: 2006
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2242845/
https://ncbi.nlm.nih.gov/pubmed/16621986
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares